AG-024322

SI-7811

AG-024322, >98% (HPLC)

CAS No. : [837364-57-5]

IUPAC Name : N-((5-(3-(4,6-Difluoro-1H-benzo[d]imidazol-2-yl)-1H-indazol-4-yl)-4-methylpyridin-3-yl)methyl)ethanamine

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : AG‑024322 potently inhibits CDK1, CDK2, and CDK4 with low‑nanomolar K_i values (1–3 nM), consistent with its profile as an ATP‑competitive pan‑CDK inhibitor. It shows broad antitumor efficacy, produces clear target engagement in vivo, and triggers apoptosis.

References : Brown A. P. et al.: Cancer Chemother Pharmacol., 62(6), 1091-101, 2008; Jessen B. A. et al.: J. Appl. Toxicol., 27(2), 133-42, 2007.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.